Oak Grove Capital LLC Aquestive Therapeutics, Inc. Transaction History

Oak Grove Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.29 - $5.21 $50,995 - $80,755	-15,500 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$4.17 - $6.73 $183,480 - $296,120	-44,000 Reduced 73.95%	15,500 $81,000
Q4 2020 Feb 17, 2021	SELL	$4.65 - $7.79 $137,175 - $229,805	-29,500 Reduced 33.15%	59,500 $318,000
Q3 2020 Nov 13, 2020	BUY	$4.12 - $9.09 $76,632 - $169,074	18,600 Added 26.42%	89,000 $432,000
Q1 2020 May 11, 2020	BUY	$1.54 - $6.75 $85,316 - $373,950	55,400 Added 369.33%	70,400 $154,000
Q4 2019 Feb 05, 2020	BUY	$3.06 - $8.78 $45,900 - $131,700	15,000 New	15,000 $87,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Grove Capital LLC with notifications on news.